Tower Research Capital (TRC)’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-228
| Closed | -$19K | – | 4454 |
|
|
2019
Q4 | $19K | Sell |
228
-1,958
| -90% | -$131K | ﹤0.01% | 1978 |
|
|
2019
Q3 | $109K | Buy |
2,186
+2,012
| +1,156% | +$80.3K | 0.01% | 1299 |
|
|
2019
Q2 | $6K | Buy |
+174
| New | +$5.68K | ﹤0.01% | 2904 |
|
|
2018
Q2 | – | Sell |
-236
| Closed | -$8K | – | 4320 |
|
|
2018
Q1 | $8K | Buy |
236
+34
| +17% | +$1.06K | ﹤0.01% | 2575 |
|
|
2017
Q4 | $6K | Sell |
202
-9,904
| -98% | -$305K | ﹤0.01% | 2843 |
|
|
2017
Q3 | $374K | Buy |
+10,106
| New | +$373K | 0.03% | 372 |
|
|
2017
Q1 | – | Sell |
-1,134
| Closed | -$38K | – | 4317 |
|
|
2016
Q4 | $38K | Buy |
+1,134
| New | +$40.2K | ﹤0.01% | 1618 |
|
|
2016
Q3 | – | Sell |
-2,989
| Closed | -$100K | – | 4892 |
|
|
2016
Q2 | $100K | Buy |
+2,989
| New | +$105K | 0.01% | 1104 |
|
|
2016
Q1 | – | Sell |
-82
| Closed | -$3K | – | 5322 |
|
|
2015
Q4 | $3K | Buy |
+82
| New | +$3.1K | ﹤0.01% | 3579 |
|
|
2015
Q3 | – | Sell |
-1,498
| Closed | -$43K | – | 5131 |
|
|
2015
Q2 | $43K | Buy |
+1,498
| New | +$41.7K | ﹤0.01% | 1490 |
|
|
2014
Q4 | – | Sell |
-1,454
| Closed | -$32K | – | 5012 |
|
|
2014
Q3 | $32K | Buy |
+1,454
| New | +$36.9K | ﹤0.01% | 1932 |
|
|
2014
Q2 | – | Sell |
-319
| Closed | -$9K | – | 4893 |
|
|
2014
Q1 | $9K | Buy |
+319
| New | +$10.6K | ﹤0.01% | 2749 |
|
|
2013
Q4 | – | Sell |
-7,469
| Closed | -$250K | – | 5102 |
|
|
2013
Q3 | $250K | Buy |
7,469
+7,362
| +6,880% | +$235K | 0.03% | 622 |
|
|
2013
Q2 | $3K | Buy |
+107
| New | +$3.58K | ﹤0.01% | 3363 |
|
Other funds holding MDCO
Tower Research Capital (TRC)'s MDCO Position: Q1 2020 in Review
Tower Research Capital (TRC) sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 228 shares — an estimated $19K sold.
Tower Research Capital (TRC) first reported a position in MDCO in Q2 2013 and held it in 14 quarters. The position peaked at $374K in Q3 2017. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Tower Research Capital (TRC) reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Tower Research Capital (TRC) sold 228 Medicines Co shares in Q1 2020, an estimated $19K.
- Tower Research Capital (TRC) first reported a position in Medicines Co in Q2 2013 and held it in 14 quarters.
- Tower Research Capital (TRC)'s Medicines Co position peaked at $374K in Q3 2017.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2020, filed 15 May 2020.